You just read:

UK Study Shows rifaximin-α (XIFAXAN® 550mg / TARGAXAN® 550mg) for Hepatic Encephalopathy May Reduce Costs to Healthcare Systems

News provided by

Norgine B.V.

31 Oct, 2016, 15:00 GMT